Cogent Biosciences Inc Cash Flow Quality Index

Latest as of December 2019: -3.68x

Cogent Biosciences Inc cash flow quality index. Cogent Biosciences Inc (COGT) has a Cash Flow Quality Index of -3.68x as of December 2019. Operating cash flow of $-8.45 Million is below net income of $2.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore COGT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-3.68x

Operating CF / Net Income

Operating Cash Flow

$-8.45 Million

USD

Net Income

$2.30 Million

USD

Data as of

Dec 2019

Most recent filing

Cogent Biosciences Inc Cash Flow Quality Index by Year (None–None)

Cogent Biosciences Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Cogent Biosciences Inc. For the full cash flow conversion analysis, see Cogent Biosciences Inc (COGT) cash conversion ratio.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.